Vantive: medicine shortages

As of 2 Nov 2026, 18 Vantive products have a reported shortage across 1 countries, covering 0 medicines.

Products short18rank #121 of 464

Medicines0active ingredients

Countries1/16

New in 90 days0-34 vs market pace

Typical duration3 monthsmedian so far

Manufacturing0%demand-driven 0%

Where

Which therapeutic classes

Why, compared with all companies

Manufacturing problemIncreased demandActive ingredient shortageDistribution or logisticsCommercial decision or withdrawalRegulatory or licensingOtherNot stated

Manufacturing problems point to the company's own supply chain; increased demand often follows a competitor's shortage or a demand shock.

Latest changes

All changes

No changes recorded yet. Changes are tracked from our daily snapshots.

When its current shortages began

Long-run trend in Canada

Canada dashboard

Canada publishes every report since 2017, so it shows whether this company is reporting more or fewer shortages over time. The current year is partial.

Against its peers

Breadth vs depth

Further right: more products short. Higher: more different medicines affected.

Medicines short

Download CSV

Medicine	Where this company is short	Products	Earliest start	Main reason	Short anywhere

Shortage data describes supply, not company finances. A shortage can mean lost sales for the supplier or extra demand for its competitors. Nothing here is investment advice; tickers are for identification only and may be out of date.